Hormone therapy in breast and prostate cancer
著者
書誌事項
Hormone therapy in breast and prostate cancer
(Cancer drug discovery and development)
Humana, 2009, c2002
- : pbk
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying targeted hormonal treatments, assess the actions of new and established agents, and illustrate the new applications of hormonal chemoprevention for breast cancer. Topics range from preclinical and clinical antiestrogens to the inhibition of estrogen synthesis and the effects of androgen withdrawal. A wide variety of proven and new agents are discussed-antiestrogens, including aromatase inhibitors (anastrozole, letrozole, and others), SERMs (tamoxifen, raloxifene, and others), and such antiandrogenic strategies as goserelin and bicalutamide.
目次
An Introduction to the Regulation of Sex Steroids for the Treatment of Cancer
V. Craig Jordan and Barrington J. A. Furr
Part I. Preclinical Antiestrogens
Antiestrogens and the Cell Cycle
Colin K. W. Watts, Owen W. J. Prall, Jason S. Carroll, Nicholas R. C. Wilcken, Eileen M. Rogan, Elizabeth A. Musgrove, and Robert L. Sutherland
Drug Resistance to Antiestrogens
Ruth M. O'Regan, Anait S. Levenson, Gale M. England, Kathy A. Yao, Henry D. Muenzner, Hiroyuki Takei, and V. Craig Jordan
Mechanisms of Liver Carcinogenesis by Antiestrogens
David H. Phillips
The Effects of Triphenylethylene Antiestrogens on Parameters of Multistage Hepatocarcinogenesis in the Rat
Yvonne P. Dragan and Henry C. Pitot
Preclinical Studies of Raloxifene and Related Compounds
Robin Fuchs-Young. Pure Antiestrogens, Alan E. Wakeling
Part II. Antiestrogens: Clinical
Tamoxifen for the Treatment of Breast Cancer
V. Craig Jordan
Clinical Utility of New Antiestrogens
Ruth M. O'Regan and William J. Gradishar
Breast Cancer Prevention with Antiestrogens
Monica Morrow and V. Craig Jordan
Part III. Inhibition of Estrogen Synthesis
Aromatase Inhibitors
Paul E. Goss and Caroline C. Reid
Clinical Utility of Aromatase Inhibitors
K. Shenton, Mitchell Dowsett, and Michael Dukes
LH-RH Agonists for the Treatment of Breast Cancer: Development and Current Status
Roger W. Blamey
Part IV. Androgen and Androgen Withdrawal
Molecular Action of Androgens
Shutsung Liao, Junichi Fukuchi, and Yung-Hsi Kao
Steroidal Antiandrogens
Fritz H. Schroeder and Albert Radlmaier
Nonsteroidal Antiandrogens
Geert J. C. M. Kolvenbag and Barrington J. A. Furr
LH-RH Agonist Role in Prostate Cancer Management
Amir V. Kaisary
Part V. Perspective on Progress
Recent Progress in Breast Cancer Research
V. Craig Jordan and Barrington J. A. Furr
「Nielsen BookData」 より